Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-10

Clinical Trial Update: Tolperisone in Acute Muscle Spasm of the Back [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of tolperisone for acute muscle spasm/back pain has completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tolperisone (tolperisone)

Snippet

Sponsor: Neurana Pharmaceuticals, Inc. | Conditions: Back Pain, Acute Pain | Phase 2 | Status: COMPLETED | Results posted: 2020-11-10